Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-04-13

Clinical Trial Update: Chlamydia Trachomatis Persistence in the Female Gastrointestinal Tract

View source ↗

Summary

A clinical trial studying persistence of Chlamydia trachomatis in the female gastrointestinal tract has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Arkansas Children's Hospital Research Institute | Conditions: Chlamydia Infection | Status: WITHDRAWN